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Sulnnlsry 
We have previously isolated,  and characterized in vitro,  two subsets of CD4 hi T cell receptor 
(TCR)  hi single positive (SP) thymocytes:  CDS-  and CD81~ In this report, we tlave analyzed 
phenotypic,  functional,  and developmental characteristics of these "late" CD4 hi SP thymocyte 
subsets. The TCK  h~ phenotype and the elimination  of T  cells expressing TCK Vo segments 
reactive with endogenous mouse mammary tumor virus (MMTV) products suggested that both 
subsets had undergone positive and negative selection. CD8-4  hi  thymocytes were functional, 
as judged by their ability to:  (a) induce lethal  graft versus host disease (GVHD); (b) survive 
and expand in peripheral lymphoid organs; and (c) proliferate, rather than undergo apoptosis, 
in response to in vitro TCK cross-linking. By contrast, CD81~ ha cells could not induce GVHD, 
were unable to expand (and perhaps even survive) in peripheral organs and underwent apoptosis 
upon TCK cross-linking.  However, when reintroduced into the thymus, these cells matured 
into  functional,  long-lived  CD8-4 hi  lymphocytes.  These  results  document  an  obligatory 
requirement for the thymic microenvironment in the final maturation of the majority of CD4  hi 
SP postselection thymocytes, and demonstrate the existence of a previously unrecognized control 
point in T  cell development. 
T 
CR-a/fl T cells develop in the thymus from immature 
precursors via an ordered sequence of phenotypic and 
functional changes (reviewed in 1-3).  The majority of the 
early  T  cell  precursors  express neither  CD8  nor  CD4 
coreceptor molecules and are therefore described as CDS-4- 
double-negatives (DN)k After successful TCK-fl rearrange- 
ment (4--6), and other less well-defined  events, these cells begin 
to express both CD4 and CD8 on the cell surface, initially 
at very low (7, 8) and then at high membrane density, to 
become CD8hi4  hi double-positive  (DP)  thymocytes. In the 
course of further maturation, positively  selected DP cells 
downregulate one of the accessory molecules and upregu- 
late the TCK to become TCK  hi cells of the CD8-4 + or 
CD8+4 -  single-positive (SP) phenotype. 
SP thymocytes have generally been regarded as functional 
equivalents of mature, peripheral SP T cells, despite pheno- 
typic differences between thymic and peripheral subsets in 
the expression of several molecules, including CD24 (heat 
stable antigen [HSA], low on SP thymocytes and negative 
1 Abbreviations  used in this~per: DN, double negative; DP, double positive; 
FCM, flow cytometry; GAPdG, goat anti-rat IgG; HSA, heat stable  antigen; 
MFI, mean fluorescence  intensity; MMTV, mouse mammary tumor virus; 
SP, single positive. 
on peripheral SP, except for recent thymic emigrants),  and 
Qa-2 (low on Sp thymocytes and high on peripheral SP) (9-12). 
However, we have demonstrated that "o70% of the CD4 § 
TCPx  hi SP thymocytes express very low levels of CD8 (un- 
detectable by flow cytometry [FCM]), intermediate levels of 
HSA, and are hyporesponsive to in vitro allogeneic stimula- 
tion in the absence of exogenous IL-2 (13). By contrast,  the 
remaining  30%  of CD4+TCK  hi  SP  cells do  not express 
CDS,  are HSA  1~ and  are self-sufficient in an  in vitro  al- 
logeneic response. Ramsdell et al. (14) obtained similar results, 
using Qa-2, rather than CD8, as a criterion for subdividing 
the CD4 + SP thymocytes.  To better understand the final 
steps in intrathymic maturation, we further examined the 
in vivo and in vitro behavior of these subsets. Throughout 
the text,  we  shall use  the term  CD4 hi  SP  for  both  cell 
subsets, since they are indeed SP by FCM; when the CD8  l~ 
phenotype is mentioned, it refers to levels of CD8 undetect- 
able by FCM, and detectable by panning;  see Materials and 
Methods,  Fig. 1, and reference 13). We show that purified 
CD8]~ hi thymocytes neither function nor expand in the pe- 
riphery. However, these cells can develop into mature, func- 
tional CD4  hi cells if reintroduced into the thymus. Thus, the 
majority of CD4hiTCR hi SP thymocytes still depend on the 
thymus for terminal  maturation. 
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Mice.  BALB/c, C57BL/6  (B6),  CB6F1,  and B6D2F1 female 
mice were purchased from the National Cancer Institute animal 
facility (Frederick, MD). B6.PL and BALB/c nu/nu breeding pairs 
were originally obtained from The  Jackson Laboratory (Bar Harbor, 
ME) and were maintained at the Memorial Sloan-Kettering Cancer 
Center. Animals were used at 5-10 wk of age, and were age- and 
sex-matched for each experiment. 
Reagents.  mAbs against  CD8 (3.168, reference 15), CD4 (ILL 
172.4) and CD25 (PC-61) (16), CD24 (J11d) and Thy-l.2 (J1J) (17), 
CD24 (M1/69, reference 18) TCR18 (H57-597,  reference 19), Va8 
(F23.1, reference 20), Thy-l.1 (19E12, reference 21), and CD44 (IM 
7.8, reference 22) were produced in our laboratory as tissue culture 
supernatant or ascites fluid, and were used without modifications 
or following conjugation to FITC. Goat anti-rat IgG (GARIG; 
cat. no. R2129) and Con A (both from Sigma Chemical Co., St. 
Louis, MO), Thy-l.2 FITC and CD4-PE (Becton Dickinson & Co., 
Mountain View, CA), CD8-PE (Coulter Corp., Hialeah, FL) CD69- 
FITC,  MEL-14-FITC,  Va3-FITC,  V~6-FITC,  and  V~11-FITC 
(Pharmingen, San Diego, CA), anti-Fc-FITC (Sigma Chemical Co.) 
anti-mouse  IgG-FITC (Fisher Biotech,  Malvern,  PA),  and the 
guinea pig complement (GIBCO BILL, Gaithersburg, MD) were 
purchased from manufacturers. Dexamethasone was obtained via 
the Memorial Sloan-Kettering Cancer Center pharmacy. 
Isolation of Cell Subsets.  Cytotoxic elimination by mAb and com- 
plement (C'), positive and negative selection of thymocytes by pan- 
ning, and FCM sorting were performed as described  previously 
(13). Thymocyte subsets were purified from c~CD8  +  C' treated 
thymocytes by panning on GARIG, and both adherent (ccCD8- 
coated cells that survived complement treatment, since they are 
CD8 l~  and nonadherent (CD8-) cells further selected for CD4  hi 
expression by either panning or FCM sorting (97-99.5% purity, 
by FCM analysis). This standard procedure was varied in order to 
confirm the phenotype of isolated cells and exclude the masking 
of CD8 molecules at the surface of DP or CD8 in' cells. Thymo- 
cytes were separated into CDS-adherent and CDS-nonadherent frac- 
tions by panning, and were then sorted without cytotoxic deple- 
tion into CDSI~ h~ cells (CD4 SP gate from CD8-adherent cells) 
and CD8-4 hi cells (CD4 SP gate from CD8-nonadherent cells). 
This isolation procedure yielded cells with identical phenotype to 
CD81~ hi and CD8- 4  hl cells obtained by a combination of cytotoxic 
depletion and panning. Splenic CD8-4 hi cells (>96% pure) were 
obtained by eliminating CD24 + (B cells and macrophages) and 
CD8 § cells by mAb  +  C' and  subsequent positive selection  of 
surviving cells by panning. 
FCMAnalysis.  Staining protocols, controls and marker place- 
ment were described  in (13),  except that experiments were per- 
formed using a FACScan  |  instrument, equipped with the LYSYS 
II software (Becton Dickinson & Co.). 5-20  x  103 events were 
analyzed  per  sample.  TCR  V~  expression was  determined  by 
single-color staining using directly conjugated anti-V~ mAb.  A 
lack of expression  of certain Va's owing to MMTV-mediated de- 
letions was used as an internal negative control. Results were nor- 
malized  to the expression of TCR. 
For the analysis of DNA  fragmentation,  106 cells from each 
population were incubated overnight in 24-well plates (Costar Corp., 
Cambridge, MA) in 2 ml of standardly supplemented KPMI/10% 
FCS. The wells were precoated with 100 #g/ml of mAb 597 or 
with PBS. Dexamethasone (10 -9 M) was used as a positive con- 
trol. The percentage of cells displaying  subdiploid DNA content 
was determined by FCM, exactly as described previously (23). For 
the cell cycle analysis, purified thymocyte subsets were fixed over- 
night in 70% ethanol, washed, resuspended in PBS containing 1,000 
Kunitz  units  RNase,  and  stained  with  propidium  iodide (500 
ng/ml).  These  samples  were  acquired  using  the  doublet-dis- 
crimination module of the FACScan  |  by dually gating on forward 
and side scatter and FL-2 area vs. width, to eliminate the inclusion 
of cell doublets. Cell cycle distribution was then analyzed using 
Multicycle software (Phoenix Flow Systems,  San Diego, CA). 
"Lethal" GVHD  1 or 2  x  106 cells of each  subset  isolated 
from BALB/c (H-2  a) donors were injected into the tail vein of 
lethally irradiated (9.5  Gy) F1  hosts  (CB6F1 or B6D2FI,  both 
H-2bxd), reconstituted with 107 T cell-depleted (J1J +  C') bone 
marrow cells of donor type. The animals were then observed daily 
until euthanized when it was judged necessary, or for over 100 d. 
Clinical signs of the disease included raised fur, weight loss, and 
loss of motility. Euthanasia was performed when the GVHD be- 
came so severe that the animals were no longer able to move around 
the cage and take food or water. This stage was defined as the end- 
point, and the GVHD was deemed lethal. Uninjected, but irradi- 
ated and reconstituted animals were used as controls. These mice 
did not exhibit any symptoms of the GVHD. 
T Cell Subset "Parking" into nu/nu Recipients.  2  x  106 purified 
thymocytes or splenocytes from BALB/c +/+  mice were injected 
intravenously  into  BALB/c  nu/nu recipients.  Recipients  were 
prescreened against  the presence of T cells in peripheral blood by 
FCM. Spleen and mesenteric lymph node cells of injected and con- 
trol animals were analyzed for CD4 and CD8 expression at indi- 
cated times.  Uninjected mice were used  as controls. 
Intrathymic Injection of T Cell Subsets.  1-2  x  106 C57BL/6 (H- 
2  b, Thy-l.2 §  cells of each subpopulation  were injected intrathymi- 
cally into lethally irradiated (9.5 Gy), syngeneic,  T cell-depleted 
(19E12 +  C') bone marrow-reconstituted B6.PL (H-2  b, Thy-l.1) 
recipients,  exactly as described (24). On day 7 post injection, and 
every third day thereafter, the mice received an intraperitoneal in- 
jection of 19E12 ascites (100 #l/animal) to deplete host-type T cells. 
At indicated times,  spleen and mesenteric lymph node cells were 
analyzed for the presence of CD4 § Thy-l.2 + and CD8 § T Thy- 
1.2 + expression  by two-color FCM. 
Proliferation Assay.  Spleen cells from mice intrathymically in- 
jected with thymocyte and splenocyte subsets >36 d before were 
analyzed for their ability to proliferate in response to 4 #g/ml of 
Con A. 10  s spleen cells were seeded in 96.weU flat-bottomed plates 
(Falcon Labware; Becton Dickinson & Co.) in 0.2 ml of  completely 
supplemented RPMI medium in the presence or absence of Con 
A. 90 h later, each well was pulsed with 1 #Ci [3H]TdR (New 
England Nuclear, Boston, MA). 6 h later, cells were harvested and 
the degree of incorporation of radiolabeled  thymidine determined 
in a beta-counter (Pharmacia LKB, Piscataway,  NJ).  Results are 
represented as the mean of triplicate wells  _+  standard  error. 
Results 
Expression of Developmental Markers and the TCR  V# Reper- 
toire  of  CD4 hi  Thymocyte  Subsets.  A  thymocyte  subset 
named  CD81~ hi was  previously described by  two  groups 
(25-27).  In  these experiments,  CD81~ hi cells were defined 
by electronic FCM gating as the cells bearing CD8 levels four 
to five times lower than  those on  typical DP  thymocytes, 
but higher than those seen on SP cells, and were shown to 
bear the TCRintCD24hiCD441~  hi phenotype (25,  26). 
Furthermore,  this  population  contained  cells  bearing  Vo 
TCRs reactive with products of endogenous mouse mam- 
mary tumor viruses (MMTVs), that are eliminated from the 
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lection may be incomplete in this intermediate subset (25). 
Based on this finding, it was concluded that CD81~ hi cells 
may have undergone positive but not negative selection (25). 
In 1990, we described a delineation of CD4 hi SP cells into 
CD8-  and CD81~ subsets and showed that they express high 
levels of CD4 and TCR, similar to those found on fully ma- 
ture peripheral cells (13).  CD8 expression was undetectable 
by FCM on CD81~ cells, and, as discussed previously, could 
only be detected by panning. By phenotypic and functional 
criteria, both subsets looked like bona fide SP thymocytes, 
but differed in requirements for the in vitro proliferation (13). 
We therefore hypothesized that CD81~ hi phenotype marks 
a late stage in the intrathymic development, immediately be- 
fore complete downregulation of CD8 and migration to the 
periphery.  Because  the  CD81~ hi  cells  described  by  other 
groups bear CD8 levels clearly detectable by FCM (25-27), 
these cells were different from our CD81~ ~ thymocytes, and 
would better be characterized as CD8 int. 
It was, however, formally possible that our CD81~ hi cells 
actually  were  CD8 ~,  i.e.,  identical  to  CD81~ hi  cells  de- 
scribed by other groups, but that their CD8 was masked by 
cytotoxic treatment used to deplete CD8 hi (DP) cells.  We 
considered this possibility unlikely because secondary reagents 
(e.g., GARIG-FITC),  as well as noncompeting antibodies 
(e.g., anti-CD8c~ for depletion and anti-CD83 for staining), 
revealed no such blocking (not shown). Furthermore, direct 
sorting of CD4 hi SP cells from thymocyte suspensions that 
have not been subjected to cytotoxic treatment yielded cells 
bearing an identical phenotype to cells obtained by a combi- 
nation of c~CD8  +  C' and panning (not shown). However, 
to independently test this possibility, we performed an ex- 
tended phenotypic analysis of gated CD8~t4 hi cells (using the 
gates described by Guidos et al. [25], and Bendelac et al. [26, 
27]) and CD8-4 hi and CD81~ hi thymocytes (isolated as de- 
scribed in Materials and Methods),  using total thymocytes 
as the reference point. In a typical experiment using BALB/c 
thymocytes (Fig. 1 A), all populations were generated from 
the same starting population (total thymocytes), either by 
selective gating (CD8 i"t) or by a combination of positive and 
negative selection by mAb  +  C' and panning (CD81~ and 
CDS-  cells).  The cells were triple-stained to reveal the ex- 
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Figure  1.  Expression of developmental 
markers on CD4~ SP thymocyte subsets of 
B6 mice.  (A) Total BALB/c thymocytes 
(Thymus),  thymocytes gated on CD8int4  hi 
cells (CD8i~t4  ~, gated  as in references 25 
and 26) or purified CD81o4  ~ and CD8- 4  hi 
thymocytes were analyzed after three-color 
staining for CD8, CD4, and the indicated 
molecule Markups were set to denote fluores- 
cence higher than that of the background. 
Numbers represent percent of cells positive 
for the given molecule. Numbers in brackets 
represent MFI, and are provided  to fadli- 
tate comparisons in the intensity of expres- 
sion of TCK,  CD24,  and  CDS.  (B) B6 
CD81~ hi (shaded histograms) and CD8-4  h~ 
(open histograms) thymocytes were purified 
as described in Materials and Methods, and 
analyzed by three-color  FCM for the ex- 
pression of CD4, CD8, and either CD69 
(left) or CD44 (right). In this experiment, 
CD81~ hi  calls  were  82.3%  CD69", 
79.9%  CD44", and CD8-4  hi cells were 
54.7%  CD69 +, 86.1% CD44 +, based on 
the marker placement to demarcate fluores- 
cence higher than that of isotype-stained 
control.  Both cell preparations were <1% 
CD8 + and >98%  CD4  hi. 
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1 A. Total thymocytes contained the major TCR-/TCR 1~ 
population,  a  minor  TCR hi  population,  and  a  TCR  int 
population between those two. While CD8int4  hi cells were 
TCR  int (mean fluorescence intensity  [MFI]  =  261),  both 
CDSl~ hi  and  CD8-4 hi  cells  were  TCR  hi,  with  a  slight 
difference between the two in TCR intensity (364 vs.  380 
MFI). CD24 showed the opposite trend; levels were very high 
and virtually identical  on  total  thymocytes and CD8int4  hi 
cells,  were reduced to a third on CD81~  hi cells,  and to less 
than a fourth in CD8-4 hi cells, in accordance with previous 
reports (13, 14). The expression of an early "activation" marker 
CD69 (25-28) correlated well with the expected maturational 
status of thymocyte subsets; its intensity was the highest on 
the  most  immature  CD8i~t4  hi cells,  and progressively de- 
creased in CD81~  hi and CD8-4 hi cells,  to reach "~45-55% 
of CD8- 4 hi cells that are intermediate to low for CD69 ex- 
pression (Fig. 1, A  and B), consistent with previous results 
(25-27).  The intensity of expression of Mel-14 (L-selectin) 
was  relatively uniform  on  all  subsets  analyzed,  although 
CD81~ hi thymocytes showed the most homogenous MEL- 
14 + staining pattern. CD4 expression was high in all popu- 
lations, while that of CD8 was intermediate (as gated) on 
CD8int4  hi cells  (roughly fourfold lower than  that on total 
thymus) and negative on CD81~  hi and CD8-4 hi cells.  Ex- 
pression of CD44 increased with maturation, so that CD8 int 
cells were largely low, while CD81~ and CDS-  cells were al- 
most identically high (Fig. 1 B and not shown). That trend 
was more obvious in B6 mice (Fig.  1 B), where the CD44 
expression is generally lower, than in BALB/c (not shown). 
Qa-2, a late differentiation antigen, was expressed at low levels 
on  the  most  mature,  CD8-4 hi cells  and was  negative on 
other populations analyzed (not shown), in accordance with 
previous results  of Ramsdell et  al.  (14). 
The expression of endogenous MMTV-reactive VO TCRs 
on thymocyte subsets is shown in Fig. 2.  This analysis re- 
vealed that  the  elimination of self-reactive Vt3's (V~3  and 
V~11 in this experiment) had occurred in both CD81~ hi and 
CD8-4 hi thymocytes. This feature further distinguishes our 
CD81~ hi cells from the CD81~ hi (more accurately CD8int4 hi) 
cells described by Guidos et al. (25) and Bendelac et al. (26, 
27), in which the elimination was incomplete (Fig. 2). There- 
fore, both the CD81~ hi and CD8-4 hi thymocyte subsets have 
the TCR phenotype of postselection thymocytes, based on 
the high TCR expression and the elimination of cells bearing 
self-reactive Vas. 
Together, these results show that CD8b4 hi ceUs are a dis- 
tinct thymocyte subset, phenotypically more mature than the 
previously identified CDSint4  hi ceils,  but  less  mature  than 
CD8-4 hi thymocytes. These three stages probably represent 
a continuum of phenotypic changes that occur as a conse- 
quence of intrathymic (selectional) contacts at an earlier stage 
(perhaps DP) in development. In the remaining part of this 
work, we sought to determine whether additional intrathymic 
contacts were required for the progression through the final 
stages of intrathymic development. 
In Vivo Responsiveness of CD4 + Thymocyte Subsets.  In our 
previous experiments, both CD81~  hi and CD8-4 hi thymo- 
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Figure 2.  Expression of Vt~s in thymocyte subsets. Thymocyte sub- 
populations were isolated/obtained  as described  for Fig. 1, and were stained 
with FITC-conjugated  mAb against V~s and PE-conjugated  oeCD4. All 
populations were selectively  gated on CD4  hi cells, and analyzed for the 
expression of TCR V~3 (solid bars), V~6 (open bars), Vt~8 (45~  hatched 
bars) and V~11 (90 ~ angle-hatched bars). V~ expression is normalized to 
the expression  of TCR. Similar  results were obtained  in two other experi- 
ments. Asterisk (*), not determined. 
cytes were shown to be restricted by MHC class II and not 
class I molecules. However, while CD8-4 ~ thymocytes were 
fully capable of proliferating to aUogeneic stimulation in vitro, 
CD81~ hi  cells  required  exogenous  IL-2  (13).  To  establish 
whether the in vitro responsiveness  of CD8~4 hi and CD8-4 hi 
thymocytes was indeed representative of their function in vivo, 
thymocyte subsets were injected intravenously into semial- 
logeneic  irradiated  hosts.  In  such  a  test,  mature  splenic 
CD8-4 hi  cells  (positive  control)  readily  induced  lethal 
GVHD  (Table  1).  In  all  experiments  performed  to  date, 
Table  1.  GVHD Mediated by CD4 *~ SP Thymocyte Subsets 
Subset  Recipient  Survival 
Experiment 1  d 
BALB/c CD81~ hi Thy  B6D2  F1  3/3  (>100) 
BALB/c CD8-4 h~ Thy  B6D2  FI  0/3  (5;5;6) 
BALB/c CD8-4 h~ Spl  B6D2  F~  0/3 (7;7;9) 
nil  B6D2  F~  3/3  (>100) 
Experiment 2 
BALB/c CD81~ hi Thy  CB6  F1  3/3  (>100) 
BALB/c CD8-4 h~ Thy  CB6  F1  0/3  (13;15;28) 
BALB/c CD8-4 hi Spl  CB6 F1  0/3  (12;15;32) 
nil  CB6 F~  3/3  (>100) 
Purified cell subsets (2  x  106 cells/recipient) were injected into lethally 
irradiated (9.5 Gy) and reconstituted  F1 recipients as described in Materi- 
als and Methods. Animals were maintained on acidified  water and ob- 
served daily for signs of GVHD.  Lethal GVHD was determined as 
described in Materials and Methods. Results are expressed as the number 
of mice surviving/total number of tested mice, with length of survival 
shown in parentheses. 
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counterpart  in  inducing  acute  GVHD.  By contrast,  the 
CDSl~ hi subset failed to mount a GVHD response,  and the 
animals that received these cells enjoyed a long-term survival 
equivalent to the control group (Table 1). Note that the ki- 
netics of GVHD was more rapid when BALB/c (H-2  a) cells 
were injected into B6D2 F1 (H-2  b￿  mice (from which they 
differ at additional minor histocompatibility loci, including 
MMTVs),  compared to  truly semiailogeneic  CB6  F1  (H- 
2bx d) animals, but that CD81~ hi cells did not react in either 
case. These results indicate that CD81~ hi cells are not only 
hyporesponsive to antigenic stimulation in vitro, but also 
cannot respond to antigenic stimulation in vivo. 
CD81~ hi Thymocytes Fail to Expand (and May Fail to Sur- 
vive) in Peripheral Lymphoid Organs.  Several  hypotheses, in- 
cluding the functional incompetence, the inability to survive 
in the periphery and the inability to properly home to lym- 
phoid organs, could explain the failure of CD81~ hi cells to 
induce GVHD. To address these possibilities, we asked whether 
CD81~ hi cells could popuhte the peripheral lymphoid organs 
of athymic syngeneic hosts after intravenous transfer. Transfer 
of either splenic or thymic CD8- 4  hi cells resulted in a selec- 
tive and progressive  increase of CD4 + ceU numbers in lym- 
phoid organs of syngeneic nude recipients (Table 2). This re- 
sult  indicated  that  donor  cells  not  only populated  host 
lymphoid organs, but also proliferated there. For example, 
2  x  106 ceils injected on day 0 yielded by day 42 an average 
increase in CD4 + cell number by 6.3  x  106 ceils (thymic 
CD8-4 hi)  and 5.7  x  106 cells (splenic  CD8-4 hi cells)  in 
donor spleens alone (experiment 2, Table 2). Assuming that 
the injected cells distributed equally throughout the lymphoid 
system, the proliferation of donor ceils was substantial. By 
contrast, lymphoid organs of animals injected with CD81~ hi 
thymocytes failed to show any increase in CD4 + cells by 3-4 
wk post injection, although some increase could be detected 
on days 10 and 15 post transfer (Table 2 and not shown). 
The percentage and numbers of total CD4 + cells in animals 
injected with CD81~ hl cells suggest that, before becoming 
Table  2.  CD8U4  hi Thymocytes Cannot Populate Peripheral Lymphoid Organs 
Percent cells in lymphoid organs of nu/nu recipients 
Spleen  Lymph nodes 
"Parked" subset  CD8 +  CD4 §  CD8 §  CD4 § 
Experiment 1 
Day 10 
nil  0.4  2.0  ND  ND 
CD81~ hi Thy  0.2  4.7  ND  ND 
CD8-4 hi Thy  0.3  4.3  ND  ND 
Day 15 
nil  1.0  2.0  ND  ND 
CD81~ hi Thy  0.8  5.7  ND  ND 
CD8-4  hl Thy  0.5  10.3  ND  ND 
Day 29 
nil  0.8  1.8  ND  ND 
CD81~ hi Thy  0.7  1.8  ND  ND 
CD8-4 hi Thy  1.1  11.2  ND  ND 
Experiment 2 
Day 42 
nil  0.7 (0.5)  1.4 (0.5)  0.4 (0.3)  3.6 (1.0) 
CD8~~ hi Thy  0.6 (0.5)  1.3 (0.4)  0.6 (0.5)  3.3 (2.3) 
CD8-4 hi Thy  0.8 (0.4)  9.7 (3.4)  0.3 (0.2)  14.1 (2.3) 
CD8-4  ~ Spl  1.2 (1.0)  8.3 (1.2)  0.6 (0.5)  12.9 (5.1) 
Syngeneic (BALB/c) nu/nu animals were injected with 2 x  106 cells of indicated phenotypes, and their peripheral lymphoid  organs analyzed. For 
experiment 1, individual  mice were analyzed  at indicated times. For experiment 2, four to five animals were analyzed  per group, and the results 
are expressed as mean  percentage (SE). Normal BALB/c animals, used as controls in these experiments contained  11.1-15.4% CD8 + and 30.2--41.6% 
CD4 + T cells. Absolute  cell numbers are discussed in the text. Results where CD4 + cells were overrepresented by more than twofold  compared 
with the control are boldfaced. Results are representative of four experiments. ND, not determined. 
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proliferation.  For example, on day 15 (experiment 1), the 
spleens  of animals injected with CD81~ hi cells  were esti- 
mated to contain 2.1  x  106 cells of donor origin (after cor- 
rection for the background). 
Since we did not have a congenic marker to follow the 
injected cells directly, we had to rely on numbers of CD8 
and CD4 T cells as an indicator of the appearance,  survival, 
and proliferation of T cells in recipient spleen and lymph nodes. 
To avoid possible misinterpretation due to leakiness of nu/nu 
mice in our colony, we selected our recipients among mice 
containing less than 2%  of T  (CD4 + and CD8 +) cells in 
the peripheral blood. The results of our experiments clearly 
segregated into two groups. Uninjected and CD81~  - 
ted animals had identical baseline levels of T cells 4 wk and 
later,  after the transfer.  This was in contrast to animals in- 
jected with thymic and splenic CD8-4 hi cells,  which dis- 
played a selective increase in CD4 + and not CD8 + T cells. 
Furthermore, a small and selective  increase in CD4 + cells 
was detected in animals receiving CD81~ hi cells  (but  not 
control animals) at early time points. Our assay therefore mea- 
sured the proliferative ability (and, most likely, survival; see 
the next section) of transferred CD4 hi subsets,  rather than 
their putative indirect effect on host T cells. Based on these 
results and on the results of apoptosis experiments (see below), 
we favor the explanation that CD81~ hs cells are probably not 
capable of surviving in peripheral lymphoid organs. How- 
ever, since our approach could not formally prove that no 
CD81~ hi cells can be detected in recipient lymphoid organs, 
we have to allow an alternative explanation, namely that some 
CD81~ hi cells may have survived after transfer. Nevertheless, 
these cells are clearly incapable of expanding (Table 2) or func- 
tioning (Table 1) in peripheral lymphoid organs. Thus, we 
conclude that CD81~ hi thymocytes were capable of homing 
to, but were unable to proliferate (and may have failed to sur- 
vive)  in peripheral lymphoid organs. 
CD81~ hi Thymocytes Are Susceptible to TCR-induced Apop- 
tosis Despite Their "Postselection"  Phenotype.  The inability of 
CD81~ h~ thymocytes to expand, (and, possibly, survive) upon 
syngeneic adoptive intravenous transfer prompted us to ex- 
amine whether these cells would undergo apoptosis after TCR 
stimulation. TCR-induced DNA fragmentation was used as 
a quantitative readout of apoptosis.  (The nature of apoptosis 
was confirmed by DNA "ladder" analysis, but this method 
was not quantitative for our purposes; data not shown.) The 
results  of this  analysis  (Fig.  3)  show  a  susceptibility  of 
CD81~ hi thymocytes to  TCR-induced apoptosis.  By con- 
trast, both CD8-4 h~ thymocytes and splenocytes were resis- 
tant.  The  apoptotic  behavior  of CD8b4 hi  cells  was  thus 
reminiscent ofDP thymocytes in normal (29) and TCK trans- 
genic (30, 31) mice. This was a surprising finding, given that 
CDSI~ hi thymocytes have almost completely downregulated 
their CD8 expression (which is detectable only by panning 
and not by direct FCM) and that they express the V~ reper- 
toire associated with completed negative selection (32, 33). 
Nevertheless,  this finding may explain the failure of CD81~ hi 
cells to mediate GVHD,  expand and perhaps even survive 
outside the thymus. 
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Figure 3.  TCR-induced apoptosis in CD4 + SP subsets. Purified CD4  hi 
subsets were incubated without stimulation (solid bars), with dexametha- 
sone (open bars) or immobilized anti-TCR-3mAb (striped bars) overnight. 
Cells were then washed, stained with propidium iodide, and analyzed for 
the number of cells containing subdiploid DNA content, diagnostic of 
apoptosis, as described in Materials and Methods. Results are represented 
as mean (SD) for two experiments. 
Intrathymic Differentiation of CD8~4 hi Cells.  We originally 
hypothesized  that  CD81~ hi  thymocytes are  precursors of 
CD8-4 hi cells, but other explanations were also plausible. 
For example, high susceptibility of CDSl~ hi thymocytes to 
apoptosis,  and their inability to survive in peripheral lym- 
phoid organs, suggested a possibility that CD81~ hi thymo- 
cytes are not precursors of thymic and peripheral CD8-4 hi 
cells, but are instead a dead-end population, marked for in- 
trathymic death. However, this explanation is difficult to recon- 
cile with the postselection phenotype of these cells. An alter- 
native to this explanation, and the one in line with our initial 
hypothesis (13) was that CD81~ hi cells will become CD8-4 hi, 
but can only complete their differentiation in the presence 
of the thymic microenvironment. We sought to distinguish 
between these possibilities  by performing intrathymic injec- 
tions  of Thy-l.2 +  thymocyte and  splenocyte subsets  and 
analyzing the phenotype and function of their progeny in 
peripheral lymphoid organs  of congenic (Thy-l.1 +)  reci- 
pients. Intrathymic transfer of thymic and splenic CD8-4 hi 
cells gave rise to long-lived (>35  d) CD8-4 hi cells in the 
spleen (not shown) and mesenteric lymph nodes (Table 3), 
with CD4/CD8 ratios among donor-derived cells of 20-60:1. 
It is likely that these cells simply migrated out of the thymus, 
populated the periphery, and proliferated there (1.75  x  106 
injected cells yielded 1.5-2  x  106 cells in mesenteric lymph 
nodes and 5-8  x  106 cells in the spleen after 42  d;  Table 
3 and not shown). Similar numbers of donor-derived cells 
were obtained by transferring CD81~ hi cells, except that we 
consistently  noted  the  presence  of  a  small  number  of 
CD4- 8 § cells. In this case, CD4/CD8 ratios varied between 
8:1 and 14:1 (Tables 3 and 4, and not shown). By contrast, 
intrathymic transfer of purified CD4-8-  precursor thymo- 
cytes yielded peripheral progeny consisting of a physiolog- 
ical  mixture  of  CD4-8 hi  and  CD8-4 hi  SP  cells  in  a 
CD4/CD8 ratio of 2:1, typically found in the donor strain 
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Microenvironment for Final Maturation 
Percent donor-derived 
(Thy 1.2)  cells (SD) 
Cells  transferred  CD4  CD8  CD4/8  index 
nil (B6)  [46.0  23.2  2.0] 
CD81~ hi Thy  23.9 (5.6)  2.2 (0.7)  10.9 
CD8-4 h~ Thy  12.4 (5.1)  0.2  (0.1)  62.0 
CD8-4  h~ Spl  14.1  (1.4)  0.5 (0.1)  28.2 
Intrathymic injections of purified thymocyte subsets (1.75 x  106/thymus) 
into Thy-1 congenic mice were performed as described in Materials and 
Methods. From day 7 after injection, host T cells were depleted by in 
vivo mAb treatment (19E12, intraperitoneally). On day 42, the presence 
of donor-derived (Thy-l.2  +) cells within CD4 and CD8 T cell subsets 
in individual mesenteric lymph nodes (results expressed as mean [SE], 
n = 3) was determined by two-color FCM. The absolute donor-derived 
cell numbers recovered from the nodes varied from 1.3-3.6  x  106 cells, 
and were comparable between different groups. These results indicated 
an expansion of intrathymically injected progeny. Similar results were 
obtained upon analysis of host splenocytes,  and in three other experiments. 
of mice. Thus,  although  some cells in our CD81~ hi prepa- 
ration developed into peripheral CD4-8 hi cells (most likely 
due to DN contamination, as discussed below), most of these 
cells gave rise to long-lived CDS-4 hi ceLls that populated pe- 
ripheral lymphoid organs. 
A possible caveat of the above experiments lies in their long 
time course. This could magnify the contribution of occa- 
sional cross-contaminants to the outcome of these experiments. 
For  example,  if  CD81~ hi  cells  were  contaminated  with 
CD8-4 hi cells at the moment  of injection,  it was possible 
that  we  actually  detected  the  progeny  of  proliferating 
CD8-4 hi cells in the periphery. Since the results shown in 
Table 2 failed to show any evidence of peripheral expansion 
of such putative contaminants, the possibility remained that 
these contaminants proliferated intrathymically. Several lines 
of evidence speak against this possibility. (a) Panning, which 
was used to separate these two subsets, is an exquisitely sen- 
sitive and successful positive selection technique, but a rela- 
tively poor negative selection technique (7, 24, 34). There- 
fore,  a  contamination  would  mostly  occur  in  the  reverse 
direction,  such that the CD8-4 hi cells might contain some 
CD81~ hi  cells,  and  not  vice versa.  Indeed,  our  results  in 
Tables 1 and 2 strongly support this notion, since even the 
long-term (over 100 d) functional assays failed to reveal con- 
tamination of CD81~ ~ cells by CDS- 4 ~ cells.  (b) A number 
of reports from different laboratories, using thymocyte labeling 
with three different markers ([3H]TdR, bromodeoxyuridine 
(BrdU), and 7-amino-actinomycin D) had concluded that adult 
CD4 + SP thymocytes contain a negligible population of cy- 
cling cells  (35-38).  It  is therefore extremely unlikely that 
CD4 + SP cells could proliferate to a  significant degree in- 
trathymicaUy. (c) Our results (Dyall, K., andJ. Nikoli6-Zugi~, 
unpublished results) show that CD4 SP thymocytes become 
undetectable in the thymus 10 d after the intrathymic injec- 
tion.  The long duration of our assay,  which was necessary 
in order to ascertain that we are looking at bona fide long- 
lived progeny of injected CD81~ hi cells,  and  not  transient 
emigrants  that will disappear  (like those in experiment  1, 
Table 2), was therefore probably not a factor in light of low 
numbers  of cycling SP  cells  and  their  relatively short  in- 
trathymic life. (d) Finally, our interpretation could indeed be 
questioned if all cycling CD4 §  SP cells were to segregate 
with CD8-4 hi and none with CD81~ hi subset.  To address 
this possibility, we purified thymocyte subsets and determined 
their cell cycle status using propidium iodide. This analysis 
Table  4.  Progeny of Intrathymically Injected CD81~ *i Cells Is Immunocompetent 
Unstimulated cells  After stimulation 
Thy-l.2 § CD4/8  Stimulation  Thy-l.2 + CD4/8 
Subset 
transferred  Percent  Index  Con A  response (SI)*  Percent  Index 
BALB/c control  27.8/9.3  3.0  328.2  25.1/8.3  3.0 
nil (B6.PL)  NA  NA  1.2  NA  NA 
DN  Thy  3.0/1.6  1.9  42.3  9.4/3.8  2.4 
CD81~ hi Thy  5.1/0.6  8.5  39.7  24.3/2.3  10.5 
Intrathymic injection (106 cells/recipient) and antibody treatment were performed as described in Fig. 3. 5 wk later, pooled splenocytes (n  =  3) 
were phenotyped for the coexpression of Thy-l.2 and either CD4 or CD8 (Unstimulated cells) and tested for their ability to proliferate in response 
to mitogenic stimulation (Stimulation) as described in Materials and Methods. Proliferating cells were also stained for the presence of donor-derived 
CD8 and CD4 cells (After culture). Results of phenotypic analysis are displayed as donor-type CD4/8 ratios and indices obtained by dividing the 
two. These parameters could not be determined for control B6.PL mice, (NA, not applicable) since their spleen cells underwent a pronounced deple- 
tion of T cells by the in vivo mAb treatment. 
* Results of the proliferation assay are displayed as stimulation indices, where SI =  mean experimental  cpm/mean control cpm. Actual cpm ( x  10 -3) 
were: 430.0 and 1.3 for BALB/c; 31.8 and 0.7 for DN; and 14.4 and 0.3 for the CD81o4  hi group, for experimental and control triplicates, respec- 
tively. Cultures without  Con A were used as a control. 
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of cycling cells (3.6%; 2.3% when corrected for the presence 
of DN contaminants), even lower than CD81~ hi cells (4.4%; 
3.3% when corrected for the presence of DN contaminants). 
By contrast,  total thymocytes, and,  in particular,  DN cells, 
contained much higher  numbers of cycling cells  (13.4  and 
37.1%, respectively). (Above percentages of cycling cells may 
actually be an overestimation,  owing to slight  overestima- 
tion of the S phase by most DNA cycle programs.) It is there- 
fore clear that  rare CD8-4 h~ contaminants  are  not capable 
of significant  intrathymic  expansion.  Furthermore,  when 
monitored  for the incorporation  of BrdU into  DNA over 
24 h, both subsets revealed  identical low labeling (3-4%), 
consistent with a noncycling nature of these cells. Together, 
these results effectively rule out the role of contamination, 
and strongly suggest that  CD81~ hi thymocytes require the 
thymus for further  development. 
Progeny of Intrathymically Injected CD81~ hi Thymocytes Is 
Functionally Immunocompetent.  Despite the phenotypic evi- 
dence that CD81~ h~ thymocytes can develop into long-lived 
(>35 d), mature peripheral CD8-4 hi cells, it was critical to 
demonstrate that these cells were immunocompetent, and not 
paralyzed or anergized.  We therefore tested the peripheral 
progeny of intrathymically injected CD81~ hi cells for their 
ability to proliferate in response to mitogenic and antigenic 
stimulation.  We stimulated total splenic lymphocytes from 
control and intrathymically injected animals,  measured their 
proliferation and determined the phenotype of proliferating 
cells.  Control BALB/c splenocytes (consisting of 37.1%  T 
cells before stimulation, with a CD4/8 ratio of 3:1) prolifer- 
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Figure 4.  Both CD4  hi SP subsets contain few cycling cells. Purified 
CD4  hi thymocyte subsets were fixed in ethanol and DNA stained with 
Pl. Total thymocytes and CD8-4-  thymocytes  are shown as controls. 
Doublets and call debris were gated out, and results from 5 x  103 ceils 
represented as DNA content histograms. Numbers represent percent of 
cells in the G1 phase, as determined by Multicycle  software  (Phoenix Flow 
Systems). Similar results were obtained in two independent experiments. 
ated vigorously in response to Con A, and the ratio of Thy- 
1.2 +  CD4/CD8  among  proliferating  cells  remained  3:1 
(Table 4). B6.PL animals, treated with ctThy-l.1 mAb in vivo, 
contain <3% T  (Thy-l.l+) cells and, under the experimen- 
tal conditions in Table 4,  these cells failed  to proliferate in 
response to Con A  (very low proliferation was only noted 
with 5  x  10  s spleen cells/well; stimulation  index  =  2.9). 
Even though by FCM analysis these cells survived the in vivo 
depletion,  most of them were probably damaged or func- 
tionally altered by such a treatment.  Therefore,  the extent 
of functional in vivo depletion was nearly complete, and al- 
lowed us to measure the proliferation of donor-derived cells 
in other experimental groups. Indeed, B6.PL animals injected 
intrathymically with either B6 DN or B6 CD81~ hi thymo- 
cytes contained •5%  Thy-l.2 + thymocytes, and these cells 
vigorously responded to Con A (Table 4). When corrected 
for the input of T cells, the response of the progeny of DN 
and CD8104  hi cells was comparable on a per cell basis to that 
of intact BALB/c T cells. The proliferating progeny of DN 
and CD81~ hi dramatically differed in CD4/CD8 ratios.  The 
CD4/8  ratio  was  2.4:1  for  the  DN  and  10.5:1  for  the 
CD81~ hi progeny.  Of note,  the representation  of Thyl.2 + 
cells within proliferating cells reflected a significant increase 
compared with their representation before proliferation (Table 
4). (Comparable results,  although with quantitatively smaller 
proliferation  [SI =  3-5], were obtained when allogeneic spleno- 
cytes were used to stimulate the progeny of intrathymically 
injected thymocytes [not shown].) These results unequivo- 
cally establish that CD81~ hi thymocytes develop into func- 
tional  CD8-4 hi  progeny  after  intrathymic  injection,  and 
demonstrate  an  obligatory  requirement  for  the  thymic 
microenvironment  in  the development  of the  majority of 
TCRhiCD4 hi SP thymocytes. 
Discussion 
In this study, we have further characterized  two subsets 
of CD4hiTCR ~ SP thymocytes. We extended their pheno- 
typic characterization to show that our CD81~ hi cells, which 
appear CDS- by direct FCM, dearly differ from previously 
described CD81~ ~ cells (25-27) that bear intermediate levels 
of CD8 (4-5x  lower than  those on DP thymocytes), and 
that we therefore call CD8  int. In addition to the expression 
of CD8, the most pronounced differences between these two 
subsets were observed in the expression of TCR, CD24, and 
CD44.  CD81~ hi cells were TCRhiCD24i~tCD44 hi,  in con- 
trast  to CD8int4 hi cells which were TCRintCD24hiCD441~ 
Furthermore,  the elimination of T cells bearing self-reactive 
Vos was complete in  CD81~ hi cells,  but  not  in  CDS~t4  hi 
cells. This is consistent with the idea that our CD81~ hi cells 
are  phenotypically  more  mature  than  CD8mt4 hi  cells,  al- 
though neither subset could produce IL-2 (13,  26) or IL-4 
(Chiocchia, G. and R. Dyall, unpublished results). On the 
other hand, we witnessed high IL-2 and IL-4 production by 
CD8-4 ~i thymocytes in response to TCR ligation in vitro 
(Chiocchia, G., and R. Dyall, unpublished results), and, in 
that respect, our CD8-4  hi cells correspond to the analogous 
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cells would also contain our CD81~ hi cells which are inac- 
tive in cytokine assays. 
The main objective of this study was to test functional 
and developmental potential of CD81~ hi and CD8-4 hi cells 
in vivo. We documented the elimination of thymocytes  bearing 
endogenous  MMTV-reactive  V~  TCKs  in  both  subsets. 
This elimination is a late event in the thymocyte develop- 
ment (31, 32) and we can therefore conclude that,  at least 
by phenotypic criteria, both subsets have undergone positive 
(TCK  upregulation,  reference 30)  and negative selection. 
However, an in vivo examination of the functional behavior 
of these two subsets revealed profound differences. Whereas 
CD8-4 hi thymocytes and control mature peripheral  CD8-4  hi 
cells induced lethal GVHD in allogeneic recipients and popu- 
lated lymphoid organs of syngeneic recipients,  CD81~ hi cells 
could not mount an immune response in vivo, and could not 
expand (and probably not survive longer than 3-4 wk) in 
peripheral  lymphoid  organs.  Furthermore,  CDSl~ hi  cells 
were sensitive  to TCK-induced apoptosis.  It will therefore 
be of interest to examine the expression of the apoptosis- 
protective protooncogene bcl-2 and related genes in these 
subsets,  since the expression of this molecule correlates very 
well to the stage of T  cell development (39-41) and to the 
susceptibility of thymocyte subsets  to Ca2+-induced apop- 
tosis  (41). 
After intrathymic injection, nonfunctional CD81~ hi thy- 
mocytes could mature into long-lived CD4 hi cells that popu- 
lated peripheral lymphoid organs. Low numbers of donor de- 
rived cells  precluded us  from distinguishing whether the 
peripheral progeny of CD81~ hi ceils was CD8-  or CD81~ 
but their longevity (Table 3) and immunocompetence (Table 
4) suggested that these cells were CD8-.  In most experi- 
ments, we could also observe a small population of CD4- 8 hi 
ceUs that developed from the donor inoculum. These cells 
could develop from a few DN contaminants (between 0.2 
and 2%, or 0.4-4  x  104 cells in our experiments) or could 
originate  from  a  novel  CD4hi8-/I~  thymic  inter- 
mediate. This latter possibility would be supported by a finding 
of a similar thymocyte intermediate, but of TCK  TM  pheno- 
type, in TCR transgenic and MHC-deficient mice (42-46). 
Experiments are in progress to distinguish between these pos- 
sibilities. Neverthdess, the presence of small numbers of con- 
taminants could not influence the difference in CD4/CD8 
ratios between the progeny of control DN and experimental 
CD81~ hi thymocytes. This  difference was  drastic  (1.9  vs. 
8.5), and it revealed that the latter cells were heavily biased 
towards becoming CD4 hi SP. 
Most importantly, we could directly demonstrate that in- 
trathymically injected CD81~ hi thymocytes yield functional 
CD4 hi SP progeny. Thus, our results demonstrate that most 
of the post-selectional CD4 hi SP thymocytes still need in- 
trathymic signal(s) for final maturation. A recent report (31) 
has indicated that TCR  hi DP cells from kl-2 transgenic and 
normal mice require the thymus to be processed into  the 
CD8-4 hi lineage. We show here that a requirement for the 
thymic microenvironment exists very late in the T  cell on- 
togeny, at the CD81~ hi stage, that is by a number of pheno- 
typic and functional features very different from DP thymo- 
cytes.  CD81~ hi thymocyte subset  had  undergone positive 
selection (as measured by the upregulation of TCK expres- 
sion) on class II molecules (13, and this study); negative se- 
lection (as measured by the deletion of thymocytes bearing 
endogenous MMTV-reactive V~s) and an almost complete 
downregulation of CD8 + , but still requires the presence of 
the thymic microenvironment for final phenotypic and func- 
tional maturation. When CD81~ hi calls were taken out of 
the thymus, and allowed to populate peripheral lymphoid 
organs of a syngeneic recipient, they failed to complete de- 
velopment  and  become  functional  CD8-4 hi  cells.  These 
findings suggest the existence of a novel developmental con- 
trol point that controls the final maturation of thymocytes. 
The nature of the late signal(s) required by CD81~ hi cells 
is not known at present. Such a signal could be transmitted 
by class II molecules, in order to verify the correct pairing 
of class II-restricted TCK and CD4  at the surface of late 
thymocytes. If this is true, it would prove the stochastic model 
of accessory molecule exclusion (reviewed in 47, 48) correct. 
However, class II signal is probably insufficient by itsdf, since 
class II molecules cannot induce TCR  hi DP thymocytes from 
bcl-2 transgenic mice to mature into CD8-4 hi cells (31). An 
alternative hypothesis, and the one we favor, would be that 
CD81~ hi cells have indeed received all signals for downregu- 
lation of CD8,  and that no further checks are required to 
test the TCR/accessory molecule matching. Instead, thymo- 
cytes  at  CD81~ hi  (or  CD41~ hi)  stage  would  require  in- 
trathymic signal(s)  to become functionally competent. This 
signal(s) would restore the capacity of late thymocytes to se- 
crete cytokines (3) and could be mediated by a cytokine, a 
membrane contact, or both. The above hypotheses are testable 
in experiments with normal and class II-deficient animals 
and experiments are underway to distinguish between them. 
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